Participant flow27

How many started, completed or left each group, period by period.

1 to 20 of 27

Period	Milestone	Group	Participants
1st Year	STARTED	Aliskiren	10,177
1st Year	STARTED	ACE-I/ARB	2,696
1st Year	STARTED	No RAS-inhibition	2,113
1st Year	COMPLETED	Aliskiren	9,120
1st Year	COMPLETED	ACE-I/ARB	2,378
1st Year	COMPLETED	No RAS-inhibition	1,933
1st Year	NOT COMPLETED	Aliskiren	1,057
1st Year	NOT COMPLETED	ACE-I/ARB	318
1st Year	NOT COMPLETED	No RAS-inhibition	180
2nd Year	STARTED	Aliskiren	10,177
2nd Year	STARTED	ACE-I/ARB	2,696
2nd Year	STARTED	No RAS-inhibition	2,113
2nd Year	COMPLETED	Aliskiren	6,212
2nd Year	COMPLETED	ACE-I/ARB	1,647
2nd Year	COMPLETED	No RAS-inhibition	1,376
2nd Year	NOT COMPLETED	Aliskiren	3,965
2nd Year	NOT COMPLETED	ACE-I/ARB	1,049
2nd Year	NOT COMPLETED	No RAS-inhibition	737
3rd Year	STARTED	Aliskiren	3,791
3rd Year	STARTED	ACE-I/ARB	982

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01454583/flow